COMMUNIQUÉ DE PRESSE publié le 24/06/2026 à 17:38, il y a 4 mois 10 jours Form 8.3 - Advanced Medical Sol Group PLC Chelverton Asset Management discloses a 1.29% interest in Advanced Medical Sol Group PLC. Public disclosure according to Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Chelverton Asset Management Advanced Medical Sol Group PLC 1.29%
BRÈVE publiée le 18/06/2026 à 12:17, il y a 4 mois 16 jours Form 8.3 Filing by Chelverton Asset Management for Advanced Medical Solutions Group Securities Asset Management Disclosure Shareholding Advanced Medical Solutions
BRÈVE publiée le 18/06/2026 à 12:17, il y a 4 mois 16 jours Formulaire 8.3 déposé par Chelverton Asset Management pour Advanced Medical Solutions Group Actionnariat Titres Gestion D'actifs Divulgation Solutions Médicales Avancées
COMMUNIQUÉ DE PRESSE publié le 18/06/2026 à 12:12, il y a 4 mois 16 jours Form 8.3 - Advanced Medical Solutions Group Plc Chelverton Asset Management discloses a 1.33% stake in Advanced Medical Solutions Group Plc in a Form 8.3 filing on 17 June 2026 Form 8.3 Financial Filing Stake Disclosure Chelverton Asset Management Advanced Medical Solutions Group Plc
BRÈVE publiée le 16/06/2026 à 15:36, il y a 4 mois 18 jours Apex Fundrock Limited annonce une prise de participation dans Reabold Resources PLC Code De Prise De Contrôle Information Sur Les Valeurs Mobilières Apex Fundrock Poste À Pourvoir Ressources Reabold
BRÈVE publiée le 16/06/2026 à 15:36, il y a 4 mois 18 jours Apex Fundrock Limited Discloses Opening Position in Reabold Resources PLC Takeover Code Securities Disclosure Apex Fundrock Opening Position Reabold Resources
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:31, il y a 4 mois 18 jours Form 8.3 - REABOLD RESOURCES PLC : Opening Position Disclosure Chelverton Asset Management discloses opening position of 3.18% in Reabold Resources PLC in accordance with Rule 8.3 of the Takeover Code Opening Position Disclosure Rule 8.3 Takeover Code Chelverton Asset Management Reabold Resources PLC
BRÈVE publiée le 11/06/2026 à 14:12, il y a 4 mois 23 jours Disclosure of Interests in Advanced Medical Solutions Group PLC Takeover Code Financial Disclosure Chelverton Asset Management Advanced Medical Solutions Investment Positions
BRÈVE publiée le 11/06/2026 à 14:12, il y a 4 mois 23 jours Déclaration des intérêts dans Advanced Medical Solutions Group PLC Code De Prise De Contrôle Déclaration Financière Positions D'investissement Solutions Médicales Avancées Gestion D'actifs De Chelsea
COMMUNIQUÉ DE PRESSE publié le 11/06/2026 à 14:07, il y a 4 mois 23 jours Form 8.3 - ADVANCED MEDICAL SOLUTIONS GROUP PLC Chelverton Asset Management discloses a 1.34% ownership in ADVANCED MEDICAL SOL GROUP PLC through Apex Fundrock Limited. Dealing took place on 10 June 2026 Dealing Disclosure Apex Fundrock Limited Ownership Disclosure Chelverton Asset Management Advanced Medical Sol Group PLC
Publié le 04/11/2026 à 18:00, il y a 10 heures The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 10 heures L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 10 heures 17 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 51 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 5 heures 1 minute Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 46 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 56 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:55, il y a 5 minutes AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Publié le 05/11/2026 à 03:10, il y a 50 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 58 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 8 heures 19 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 35 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
